byRadboud UniversityScanning electron micrograph of Mycobacterium tuberculosis bacteria, which cause TB. Credit: NIAIDA higher dose of the antibiotic rifampicin does not improve survival rates for pat
byRadboud UniversityScanning electron micrograph of Mycobacterium tuberculosis bacteria, which cause TB. Credit: NIAIDA higher dose of the antibiotic rifampicin does not improve survival rates for pat
by Lori SolomonThe U.S. Food and Drug Administration has approved a new indication for Breyanzi (lisocabtagene maraleucel) for treating adults with marginal zone lymphoma (MZL) who have failed treatme
by Lori SolomonThe U.S. Food and Drug Administration has approved a new indication for Breyanzi (lisocabtagene maraleucel) for treating adults with marginal zone lymphoma (MZL) who have failed treatme